ALBERT LUSBY: Open Payments
NPI 1598077935 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 61 payments from 16 companies in 2025. Trend: 2023 $539 · 2024 $1,512 · 2025 $1,096
Food & beverage: $1,096
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $209 |
| Novo Nordisk Inc | 12 | $204 |
| AstraZeneca Pharmaceuticals LP | 8 | $145 |
| Phathom Pharmaceuticals, Inc. | 5 | $95 |
| Lilly USA, LLC | 4 | $82 |
| Astellas Pharma US Inc | 4 | $75 |
| ABBVIE INC. | 2 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Amgen Inc. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
Products named: Wegovy, VOQUEZNA, JARDIANCE, NURTEC ODT, Veozah, AIRSUPRA, Ozempic, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
